Sign Up Today and Learn More About ReCode Therapeutics Stock
Invest in or calculate the value of your shares in ReCode Therapeutics or other pre-IPO companies through EquityZen's platform.
ReCode Therapeutics Stock (REOT)
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
About ReCode Therapeutics Stock
Founded
2015
Headquarters
Dallas, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
ReCode Therapeutics Press Mentions
Stay in the know about the latest news on ReCode Therapeutics
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT1100 for the Treatment of Primary Ciliary Dyskinesia
businesswire • Aug 03, 2024
New Article Published in Science Highlights the Potential of ReCode Therapeutics' Systemic Lung Delivery and CFTR ...
businesswire • Jun 25, 2024
Lung-targeting lipid nanoparticles with CRISPR components successfully treat cystic fibrosis mouse models
phys • Jun 25, 2024
ReCode Therapeutics on LinkedIn: #clinicaltrials #primaryciliarydyskinesia #pcd
linkedin • Jun 25, 2024
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
finance • Jun 25, 2024
ReCode Therapeutics Management
Leadership team at ReCode Therapeutics
Co-Founder
Daniel Siegwart
Co-Founder
Philip Thomas
Join now and verify your accreditation status to gain access to:
- ReCode Therapeutics current valuation
- ReCode Therapeutics stock price
- Available deals in ReCode Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in ReCode Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like ReCode Therapeutics through EquityZen funds. These investments are made available by existing ReCode Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ReCode Therapeutics stock?
Shareholders can sell their ReCode Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
